Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.410
+0.040 (2.92%)
At close: Apr 24, 2026, 4:00 PM EDT
1.350
-0.060 (-4.26%)
After-hours: Apr 24, 2026, 4:00 PM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $123.03 million as of April 24, 2026. Its market cap has decreased by -25.64% in one year.
Market Cap
123.03M
Enterprise Value
109.29M
1-Year Change
-25.64%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has decreased from $125.22M to $123.03M, a decrease of -1.75%. That is a compound annual growth rate of -0.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 123.03M | -29.04% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KALA BIO | 126.50M |
| Verrica Pharmaceuticals | 119.91M |
| Oncolytics Biotech | 119.61M |
| Pyxis Oncology | 119.38M |
| NeOnc Technologies Holdings | 119.08M |
| Aardvark Therapeutics | 117.59M |
| Cardiff Oncology | 117.59M |
| Immunic | 114.82M |